Portal Hypertension Management Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and C

As per the report, the portal hypertension management market size has grown strongly in recent years. It will grow from $2.88 billion in 2023 to $3.07 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The portal hypertension management market size is expected to see strong growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16515&type=smp

Increasing Prevalence Of Liver Diseases Such As Hepatitis Fuels Portal Hypertension Market
An increasing prevalence of liver diseases such as hepatitis is expected to propel the growth of the portal hypertension management market going forward. Liver disease refers to a range of conditions that affect the liver's structure or function, often leading to symptoms such as jaundice, fatigue, and abdominal pain, with causes including viral infections, alcohol abuse, or metabolic disorders. Liver diseases are occurring due to alcohol consumption, viral hepatitis infections, obesity-related fatty liver disease, and metabolic disorders. Portal hypertension management in liver disease aims to reduce pressure in the portal vein system, which helps alleviate complications such as variceal bleeding, ascites, and hepatic encephalopathy, improving patient outcomes. For instance, in September 2022, according to Cancer Australia, an Australia-based government cancer agency, around 2,905 new cases of liver cancer were diagnosed in Australia in 2022 (2,113 males and 792 females). Further, the risk of developing liver cancer by age 85 is predicted to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for men, and 1 in 195, or 0.51%, for women. Therefore, the increasing prevalence of liver diseases is driving the portal hypertension management market.

Adoption Minimally Invasive Devices For Portal Hypertension Management
Major companies in the portal hypertension management market are adopting advanced minimally invasive devices to enhance treatment outcomes and reduce procedural risks. Minimally invasive devices are medical instruments or tools designed to perform procedures with minimal disruption to surrounding tissues, typically through small incisions or natural body openings. For instance, in November 2023, Medtronic Plc, a US-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for Symplicity Spyral renal denervation (RDN). It is a minimally invasive device for treating hypertension. This innovative procedure employs radiofrequency energy to target nerves near the kidneys, effectively calming them to manage hypertension.

The portal hypertension management market covered in this report is segmented -

1) By Treatment Type: Medications, Non-Surgical Procedures, Surgery
2) By Procedure Type: Transjugular Intrahepatic Portosystemic Shunt (TIPS), Other Procedure Types
3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16515&type=discount

Major companies operating in the portal hypertension management market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Merck & Co., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals LLC., Lupin Ltd., Daiichi Sankyo, Dr. Falk Pharma GmbH, Cumberland Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Chiasma Inc., Debiovision Inc.

Contents of the report:
1. Executive Summary
2. Portal Hypertension Management Market Report Structure
3. Portal Hypertension Management Market Trends And Strategies
4. Portal Hypertension Management Market - Macro Economic Scenario
5. Portal Hypertension Management Market Size And Growth
…..
27. Portal Hypertension Management Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/portal-hypertension-management-global-market-report

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.